Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke

被引:68
作者
Srivastava, Pranay [1 ]
Cronin, Chunxia G. [2 ]
Scranton, Victoria L. [1 ]
Jacobson, Kenneth A. [3 ]
Liang, Bruce T. [2 ]
Verma, Rajkumar [1 ]
机构
[1] UConn Hlth, Dept Neurosci, Farmington, CT 06032 USA
[2] UConn Hlth, Calhoun Cardiol Ctr, Farmington, CT 06032 USA
[3] NIDDK, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
PROTECTS; INFLAMMATION; EXPRESSION; RECOVERY; RELEASE; INJURY; CELLS;
D O I
10.1016/j.expneurol.2020.113308
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Stroke remains a leading cause of disability in the United States. Despite recent advances, interventions to reduce damage and enhance recovery after stroke are lacking. P2X4R, a receptor for adenosine triphosphate (ATP), regulates activation of myeloid immune cells (infiltrating monocytes/macrophages and brain-resident microglia) after stroke injury. However, over-stimulation of P2X4Rs due to excessive ATP release from dying or damaged neuronal cells can contribute to ischemic injury. Therefore, we pharmacologically inhibited P2X4R to limit the over-stimulated myeloid cell immune response and improve both acute and chronic stroke recovery. We subjected 8-12-week-old male and female wild type mice to a 60 min right middle cerebral artery occlusion (MCAo) followed by 3 or 30 days of reperfusion. We performed histological, RNA sequencing, behavioral (sensorimotor, anxiety, and depressive), and biochemical (Evans blue dye extravasation, western blot, quantitative PCR, and flow cytometry) analyses to determine the acute (3 days after MCAo) and chronic (30 days after MCAo) effects of P2X4R antagonist 5-BDBD (1 mg/kg P.O. daily x 3 days post 4 h of MCAo) treatment. 5-BDBD treatment significantly (p <.05) reduced infarct volume, neurological deficit (ND) score, levels of cytokine interleukin-1 beta (IL-1 beta) and blood brain barrier (BBB) permeability in the 3-day group. Chronically, 5-BDBD treatment also conferred progressive recovery (p <.05) of motor balance and coordination using a rotarod test, as well as reduced anxiety-like behavior over 30 days. Interestingly, depressive-type behavior was not observed in mice treated with 5-BDBD for 3 days. In addition, flow cytometric analysis revealed that 5-BDBD treatment decreased the total number of infiltrated leukocytes, and among those infiltrated leukocytes, pro-inflammatory cells of myeloid origin were specifically reduced. 5-BDBD treatment reduced the cell surface expression of P2X4R in flow cytometry-sorted monocytes and microglia without reducing the total P2X4R level in brain tissue. In summary, acute P2X4R inhibition protects against ischemic injury at both acute and chronic time-points after stroke. Reduced numbers of infiltrating pro-inflammatory myeloid cells, decreased surface P2X4R expression, and reduced BBB disruption are likely its mechanism of neuroprotection and neuro-rehabilitation.
引用
收藏
页数:13
相关论文
共 31 条
[1]   Investigation of the Inhibitory Effects of the Benzodiazepine Derivative, 5-BDBD on P2X4 Purinergic Receptors by two Complementary Methods [J].
Balazs, Bernadett ;
Danko, Tamas ;
Kovacs, Gergely ;
Koeles, Laszlo ;
Hediger, Matthias A. ;
Zsembery, Akos .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (01) :11-24
[2]   Purinergic signalling and disorders of the central nervous system [J].
Burnstock, Geoffrey .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (07) :575-590
[3]   P2X4 receptors expressed on microglial cells in post-ischemic inflammation of brain ischemic injury [J].
Cheng, Rui-dong ;
Ren, Jing-jing ;
Zhang, Yan-yan ;
Ye, Xiang-ming .
NEUROCHEMISTRY INTERNATIONAL, 2014, 67 :9-13
[4]   Characterization of the antagonist actions of 5-BDBD at the rat P2X4 receptor [J].
Coddou, Claudio ;
Sandoval, Rodrigo ;
Jose Hevia, Maria ;
Stojilkovic, Stanko S. .
NEUROSCIENCE LETTERS, 2019, 690 :219-224
[5]   Absence of the chemokine receptor CCR2 protects against cerebral Ischemia/reperfusion injury in mice [J].
Dimitrijevic, Olivier B. ;
Stamatovic, Svetlana M. ;
Keep, Richard F. ;
Andjelkovic, Anuska V. .
STROKE, 2007, 38 (04) :1345-1353
[6]   MMP-9, a Potential Target for Cerebral Ischemic Treatment [J].
Dong, Xue ;
Song, Yu-Ning ;
Liu, Wei-Guo ;
Guo, Xiu-Li .
CURRENT NEUROPHARMACOLOGY, 2009, 7 (04) :269-275
[7]   Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study [J].
Feigin, Valery L. ;
Mensah, George A. ;
Norrving, Bo ;
Murray, Christopher J. L. ;
Roth, Gregory A. .
NEUROEPIDEMIOLOGY, 2015, 45 (03) :230-236
[8]   Clematichinenoside protects blood brain barrier against ischemic stroke superimposed on systemic inflammatory challenges through up-regulating A20 [J].
Han, Dan ;
Fang, Weirong ;
Zhang, Rui ;
Wei, Jie ;
Kodithuwakku, Nandani Darshika ;
Sha, Lan ;
Ma, Wenhuan ;
Liu, Lifang ;
Li, Fengwen ;
Li, Yunman .
BRAIN BEHAVIOR AND IMMUNITY, 2016, 51 :56-69
[9]   P2X4 Forms Functional ATP-activated Cation Channels on Lysosomal Membranes Regulated by Luminal pH [J].
Huang, Peng ;
Zou, Yuanjie ;
Zhong, Xi Zoe ;
Cao, Qi ;
Zhao, Kexin ;
Zhu, Michael X. ;
Murrell-Lagnado, Ruth ;
Dong, Xian-Ping .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (25) :17658-17667
[10]   Targeting neutrophils in ischemic stroke: translational insights from experimental studies [J].
Jickling, Glen C. ;
Liu, DaZhi ;
Ander, Bradley P. ;
Stamova, Boryana ;
Zhan, Xinhua ;
Sharp, Frank R. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2015, 35 (06) :888-901